DUBLIN, June 30, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/hmdflj/outlook_of_global) has announced the addition of the "Outlook of Global Biologic Drug Discovery Outsourcing Market" report to their offering.
The global biologic drug discovery outsourcing market will likely grow in a CAGR of 23% between 2015 and 2020, and may reach $11.4 B by 2020.
It has been widely recognized that today therapeutic biologics (or biopharmaceuticals) have become a new but important type of medication. They provide not only a new class of therapeutics for those diseases previously treated with small molecule drugs, but also a type of novel treatment for those previously untreatable diseases. The global biopharmaceutical market has thus been experiencing fast growth in the recent years. A growing number of biologic drugs have also become blockbusters.
Among all types of therapeutic biologics, discovery of novel antibodies and their related conjugates with not only high affinity and target specificity but also good druggability and biological functionality, has been the main focus of drug companies at present. Moreover, as they have demonstrated great promise in a number of therapeutic areas, it is expected that search for more effective antibodies of all types will be still the key priority of global drug companies in the foreseeable future.
However, in this field a large part of the discovery work is carried out through partnership between major pharma companies and those biotech companies that posses the cutting edge technologies and platforms in biologic drug discovery. Almost all major companies have been aggressively searching for such a type of biotechnology companies for acquisition, licensing, or collaboration.
The report, Outlook of Global Biologic Drug Discovery Outsourcing Market, provides the unique insights into the current development state of the global biologic drug discovery outsourcing market. The report is designed to reveal the latest development trends and the future growth potentials of this new outsourcing market. It contains the in-depth analyses on the latest strategies and outsourcing demands in biologic drug discovery research of global major drug companies and R&D-focused small biotech companies. It also includes the detailed analyses on the primary service models and evolving technologies in this field.
The report provides the unique insights into the current development states and the future growth potentials of the global biologic drug discovery outsourcing market. It is a must-read book to all pharmaceutical and biopharmaceutical companies that seek biologic drug discovery outsourcing opportunities, drug discovery-focused outsourcing service providers that need to conceive their future development directions, and venture capital investors that are looking for investment opportunities in the global pharmaceutical industry.
Key Topics Covered:
- Current states of global biologic drug R&D
- Latest trends of global biologic drug discovery outsourcing
- Future growth forecast of global biologic drug discovery outsourcing market
Chapter One - Current States of Global Biologic Drug R&D
1.2 Global biopharmaceutical market experiencing fast growth
1.3 Major pharma companies experiencing growing shares of biologic drug sales in their total sales revenues
1.4 Biologic drugs becoming R&D focuses of global major pharma companies
1.5 Current states of global biologic drug R&D
Chapter Two - Latest Trends of Global Biologic Drug Discovery Outsourcing
2.2 Definitions of various types of antibodies
2.3 Major pharma companies increasingly licensing new biologic drug discovery technologies from specialty biotech companies
2.4 Latest trends of mAb drug discovery outsourcing
2.5 Latest trends of bispecific antibody (bAb) drug discovery outsourcing
2.6 Latest trends in other types of antibody drug discovery outsourcing
2.7 Latest trends of ADC discovery outsourcing
2.8 Latest trends of drug discovery outsourcing on immunotherapy
2.9 Examples of biotech specialists possessing cutting edge biologic drug discovery technologies and platforms
Chapter Three - Future Growth Forecast of Global Biologic Drug Discovery Outsourcing Market
3.2 Future growth of global pharmaceutical market expected to be driven primarily by biologics
3.3 Major pharma companies expected to more focus on biologic drug R&D in future
3.4 Analysis of drug companies' future outsourcing demands and strategies on biologic drug discovery
3.5 Analysis of potential hurdles for future growth of global biologic drug discovery outsourcing market
3.6 Analysis of future biologic drug discovery outsourcing penetration
3.7 Analysis of future growth potentials of global biologic drug discovery outsourcing market
3.8 Analysis of future biologic drug discovery outsourcing patterns
For more information visit http://www.researchandmarkets.com/research/hmdflj/outlook_of_global
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets